Vaccinul personalizat împotriva melanomului a redus cu 42% riscul de recidivă sau deces

Sinteza CondicaRealizată cu ajutorul inteligenței artificiale

1 min de lectură

23 oct. 2026, 03:5123.10, 03:5124 oct. 2026, 14:5424.10, 14:54

19 surse

CONSULTĂ PUBLICAȚIILE ORIGINALE

01independent.co.ukmRNA cancer vaccine slashes melanoma death or recurrence risk by 42%
02investing.comMerck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall
03news.google.comA novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning - AP News
04nytimes.comCancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
05youtube.comA cancer vaccine is reducing the chances that melanoma patients’ tumors return
06time.comA Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
07arstechnica.comModerna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
08news.google.comModerna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% - Ars Technica
09yahoo.comFirst-of-its-kind cancer vaccine cuts risk of melanoma returning by 42% in major trial
10news.google.comDetailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial - STAT
11news.google.comFirst-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients - The New York Times
12nature.comModerna mRNA vaccine almost halves the risk of skin cancer returning
13gizmodo.comThese Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free
14news.google.comFirst personalised cancer vaccine cuts risk of disease returning in major trial - BBC
15cbc.caA novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study
16nbcnews.comPersonalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial
17theguardian.com‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows
18news.google.comModerna mRNA vaccine almost halves the risk of skin cancer returning - Nature
19wired.comNew mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Independent · Stock Market News · "news" - Google News + 11

Moderna și Merck au raportat că vaccinul personalizat cu ARN mesager a redus cu 42% riscul de recidivă a melanomului sau de deces, comparativ cu tratamentul standard, într-un studiu în stadiu avansat.

Moderna și Merck au raportat rezultatele unui studiu în stadiu avansat privind un vaccin personalizat cu ARN mesager pentru pacienți cu melanom. Comparativ cu tratamentul standard, vaccinul a redus cu 42% riscul de recidivă a cancerului sau de deces pe parcursul a doi ani. Companiile au prezentat vaccinul drept experimental.

Această sinteză este realizată cu ajutorul inteligenței artificiale și poate conține erori. Consultă sursele originale pentru verificarea informațiilor.

Înapoi la știri